CA9 and cardiovascular disorder: Given its co-localization with hypoxia, and plaque hypoxia correlating with total lesion burden and lesion vulnerability, we explored the use of plaque-resident CAIX and circulating sCAIX, as a biomarker for cardiovascular disease outcome.